24/05/2022
01:50:11
Produtos ADVFN
Fale Conosco
Cadastro Gratis
Login
Forum
Monitor
Cotação
Gráfico
Book
Notícias
Moeda
Portfólio
Rankings
Scanner
Bolsas
PLUS1
Ferramentas
Mercados
Investimentos
ADVFN CURSO
Brasa
Gráficos interativos, cotações e ferramentas de análise gratuitas
REGISTRE-SE AGORA!
Início
Investir
Ações
Canadá
TSX
Acerus Pharmaceuticals Corporation
(ASP)
Balanços
Cotação
Gráfico
Book
Negócios
Notícias
Balanços
Histórico
Acerus Pharmaceuticals Corporation (ASP) Fundamentals
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
SHARE INFORMATION
Market Cap
$ 30.135.348
Shares Outstanding
7.707.747
Float
-
Percent Float
0,0%
Short Interest
1.128,00
Short Percent Float
100,0%
Short Interest Ratio
0,150701
Short Interest Date
2022-05-15
Latest Fiscal Dividend Per Share
$ 0,00
Latest Fiscal Revenue
$ -5.223.760
Latest Fiscal EPS
$ -5,06
Latest Fiscal Date
2021-12-31
DIVIDENDS
Dividend (3 Years)
$ 0,00
Dividend (5 Years)
$ 0,00
Ex Dividend Date
-
Dividend Rate
$ 0,00
Dividend Yield
0,0%
Payment Cash
-
HOLDERS
Institutions
1
Institutional Holdings Date
2020-04-30
Institutional Bought Previous 3 Months
-
Institutional Holdings Percent
0,0%
Institutional Sold Previous 3 Months
-
Insider Holdings Date
-
Insider Bought Previous 3 Months
-
Insider Holdings Percent
0,0
Insider Sold Previous 3 Months
-
Insider Shares Owned
1.435.197.462
TRADING INFO
52 Week High
$ 11,00
52 Week Low
$ 2,96
52 Week High Change
$ -60,90
21 Day Moving Average
$ 5,279
21 Day Extended Moving Average
$ 5,4049
50 Day Moving Average
$ 7,3172
50 Day Extended Moving Average
$ 6,5345
200 Day Moving Average
$ 7,4493
200 Day Extended Moving Average
$ 7,58
10 Day Average Volume
192
20 Day Average Volume
2.845
30 Day Average Volume
2.080
50 Day Average Volume
1.387
Alpha
0.002072
Beta
1.089451
Standard Deviation
0.34193
R2
0.016901
7 Day Price Change
$ -0,99
7 Day Percent Change
-20,2%
21 Day Price Change
$ -0,95
21 Day Percent Change
-19,55%
30 Day Price Change
$ -3,09
30 Day Percent Change
-44,14%
Month to Date Price Change
$ -0,95
Month to Date Percent Change
-19,55%
Quarter to Date Price Change
$ -5,09
Quarter to Date Percent Change
-56,56%
180 Day Price Change
$ -4,09
180 Day Percent Change
-51,13%
200 Day Price Change
$ -4,09
200 Day Percent Change
-51,13%
Year to Date Price Change
$ -1,09
Year to Date Percent Change
-21,8%
Acerus Pharmaceuticals Corporation (ASP) Key Ratios
PROFITABILITY
EBIT Margin
-959,2%
EBITDA Margin
-940,9%
Pre-Tax Profit Margin
-858,1%
Profit Margin Count
0,0%
Gross Margin
55,9%
Profit Margin TOT
0,0%
INCOME STATEMENTS
Revenue
$ 3.311.646
Revenue Per Share
$ 0,429652
Revenue (3 Years)
$ 0,00
Revenue (5 Years)
$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book
-0,58
Total Debt To Equity
2,61
Int Coverage
-8,90
Current Ratio
0,50
Leverage Ratio
-1,30
Quick Ratio
0,20
Long Term Debt To Capital
0,68
VALUATION MEASURES
PE Ratio
-1,30
Enterprise Value
$ 70.855.616
Price to Sales
9,1004
Price to Free Cash
-1,00
PE High Last 5 Years
7,70
Price To Book
18,06
Price To Cash Flow
595,00
PE Low Last 5 Years
-2,20
Price to Tangible Book
-0,58
MANAGEMENT EFFECTIVENESS
Receivables Turnover
2,50
Invoice Turnover
0,30
Assets Turnover
0,10
Return Assets
-93,76
Return on Equity
415,09
Return on Capital
-316,75
Acerus Pharmaceuticals Corporation (ASP) Profile
PROFILE INFO
Issue Type
CS
SEC Type
EQS
Auditor
PricewaterhouseCoopers LLP
CEO
Edward Gudaitis
Emplyoees
14
Last Audit
UE
CIK
0001527246
Industry
Drug Manufacturers
Sector
Healthcare
NAICS
Pharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address
7025 Langer Drive
Suite 205
Mississauga, ON L5N 0E8
Website
https://www.aceruspharma.com
Facsimile
+1 905 569-1809
Telephone
+1 289 326-5789
Email
IR@aceruspharma.com
Seu Histórico Recente
TSX
ASP
Acerus Pha..
Registre-se agora
para acompanhar essas ações ao vivo no Monitor ADVFN.
O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é
completamente grátis
para você usar.
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte:
suporte@advfn.com.br
ou (11) 4950 5808.
Login
Login inválido. Tente novamente.
Usuário
Senha
Esqueci minha senha
suporte@advfn.com.br
(11) 4950 5808
Não possui uma conta?
Crie uma agora